Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators.
OBJECTIVES: We developed a prognostic strategy for quantifying the long-term risk of coronary heart disease (CHD) events in survivors of acute coronary syndromes (ACS). BACKGROUND: Strategies for quantifying long-term risk of CHD events have generally been confined to primary prevention settings. T...
Main Authors: | Marschner, I, Colquhoun, D, Simes, R, Glasziou, P, Harris, P, Singh, B, Friedlander, D, White, H, Thompson, P, Tonkin, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Comparison of fat intake in Australian and New Zealand CHD patients: The LIPID (long term intervention with Pravastatin in ischaemic disease) study
by: Nestel, P, et al.
Published: (2002) -
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
by: Colquhoun, D, et al.
Published: (2004) -
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
by: Tonkin, A, et al.
Published: (2000) -
Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
by: Reid, I, et al.
Published: (2001) -
Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long‐term Intervention with Pravastatin in Ischaemic Disease (LIPID) study
by: Dianna Magliano, et al.
Published: (2003-12-01)